Assistant Professor of Psychiatry
Associate Program Director, Child & Adolescent Psychiatry
College of Medicine
University of Kentucky
Needs StatementOpioid overdose continues to be a major public health problem in the United States. It has contributed significantly to accidental deaths among those who use or misuse illicit and prescription opioids. In fact, U.S. overdose deaths involving prescription opioid analgesics increased to about 19,000 deaths in 2014--more than three times the number in 2001.
Target AudiencePhysicians, Pharmacists, Health Administrators, Nurses, Nurse Practitioners, Social Workers, Drug and Alcohol Counselors, and practitioners of addiction medicine.
ObjectivesUpon completion of this activity, participants will be able to:
1. Review the prevelance of opioid use in adults and youth
2. Discuss the morbidity and mortality associated with opioid use in youth
3. Identify the evidence-based treatments of opioid use disorder in adolescence
AccreditationThe University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This knowledge-based activity has been assigned UAN 0022-0000-16-072-H01-P and will award 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.
Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.
Faculty DisclosureNo speakers, authors, or planners have any relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.